What Is Dechloroetizolam
What Is Dechloroetizolam? Chemical Classification
Dechloroetizolam belongs to the thienotriazolodiazepine class—a group of compounds structurally related to benzodiazepines. The key distinction is the replacement of the benzene ring with a thiophene ring .
Key Chemical Identifiers
Structural Characteristics
Dechloroetizolam is structurally similar to etizolam, differing by the absence of a chlorine atom at the 2′ position on the phenyl ring—hence the “dechloro-” prefix . This structural modification results in distinct pharmacological properties compared to its parent compound.
Calculated Properties
- cLogP: 3.55 (lipophilicity indicator)
- Hydrogen Bond Acceptors: 5
- Hydrogen Bond Donors: 0
- Rotatable Bonds: 2
- Ring Count: 4 (including a 7-membered diazepine ring)
- TPSA: 43.07 Ų
Dechloroetizolam vs. Etizolam: Structural Comparison
Pharmacology and Mechanism of Action
Dechloroetizolam, like other thienodiazepines, acts as a positive allosteric modulator of the GABA-A receptor. By enhancing the affinity of GABA for its binding site, it promotes inhibitory neurotransmission in the central nervous system .
Key Pharmacological Effects (Observed in Research)
- Sedation – Dose-dependent CNS depression
- Anxiolysis – Anxiety reduction in preclinical models
- Muscle relaxation – Reduced motor tone
- Hypnotic effects – Sleep induction properties
- Anticonvulsant activity – Seizure threshold modulation
- Amnesic properties – Memory formation interference
Relative Potency
According to harm reduction data, dechloroetizolam is approximately 0.33 to 0.5 times as potent as etizolam, with a rapid onset but significantly longer duration of action .
Dechloroetizolam Dosage Guidelines for Research
For laboratory and preclinical research purposes, the following dosage ranges have been reported in harm reduction literature:
Onset and Duration:
Note: These ranges are based on user-reported data and harm reduction sources. Laboratory research should always begin with the lowest feasible concentrations.
Metabolism and Identification
Scientific studies have characterized the in vitro phase I metabolism of dechloroetizolam using human liver microsomes. Key findings include:
- Primary metabolites: At least one monohydroxylated metabolite identified
- Secondary metabolites: Dihydroxylated metabolites also detected
- No observed: Desalkylation, dehalogenation, or carboxylation products
Analytical Detection Methods
Dechloroetizolam can be characterized using:
- Nuclear Magnetic Resonance (NMR) spectroscopy
- Gas Chromatography–Electron Ionization-Mass Spectrometry (GC-EI-MS)
- Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)
- Liquid Chromatography–Quadrupole Time-of-Flight-Mass Spectrometry (LC-QTOF-MS)
- Infrared (IR) spectroscopy
These methods are essential for forensic toxicology and analytical chemistry applications.
Scientific Research Applications
Dechloroetizolam has several legitimate research applications:
1. Analytical Chemistry
Used as a reference standard for developing and validating analytical methods to detect novel benzodiazepines in biological samples .
2. Forensic Toxicology
Essential for identifying and quantifying designer benzodiazepines in post-mortem and toxicology screening .
3. Pharmacology Research
Studied for its interaction with GABA-A receptors and characterization of thienodiazepine structure-activity relationships .
4. Metabolism Studies
Investigating phase I and phase II metabolic pathways to understand biotransformation and elimination .
Safety and Harm Reduction Considerations
Dechloroetizolam poses significant risks that researchers must acknowledge:
Key Risks
- Respiratory Depression – High doses can suppress breathing, especially when combined with other CNS depressants
- Cognitive Impairment – Drowsiness, reduced motor coordination, slurred speech
- Amnesia – Dose-dependent memory formation interference
- Paradoxical Effects – Agitation or aggression in some cases
Critical Warnings
- Do not combine with alcohol, opioids, GHB/GBL, or other depressants—risk of fatal overdose increases dramatically
- Tolerance and dependence develop rapidly with repeated use
- Compulsive redosing is a known behavioral risk due to false feelings of sobriety
- Withdrawal can be life-threatening (seizures, delirium) after dependence formation
⚠️ Research Use Only: Dechloroetizolam is not approved for human consumption. All handling should occur in controlled laboratory settings with appropriate safety protocols.
Legal Status by Region
Important: Laws regarding research chemicals vary significantly by jurisdiction. Researchers must verify local regulations before procurement or handling.
Frequently Asked Questions (FAQs)
Q1: Is dechloroetizolam the same as etizolam?
No. While structurally related, dechloroetizolam lacks the chlorine atom found in etizolam, resulting in different potency and duration profiles .
Q2: What is the CAS number for dechloroetizolam?
The CAS registry number is 40054-73-7 .
Q3: How is dechloroetizolam metabolized?
Human liver microsomes produce monohydroxylated and dihydroxylated metabolites. No desalkylation or dehalogenation products have been observed .
Q4: Is dechloroetizolam legal to buy for research?
Legality depends on your jurisdiction. Many countries regulate it under analog acts or specific designer drug legislation. Always consult local laws before procurement.
Q5: What is the molecular weight of dechloroetizolam?
The molecular weight is 308.4 g/mol .
Conclusion: Dechloroetizolam in Scientific Research
Dechloroetizolam represents an important compound in the ongoing study of thienodiazepine structure-activity relationships and designer benzodiazepine analogs. Its distinct pharmacological profile—lower potency but longer duration than etizolam—makes it a valuable reference standard for analytical and forensic toxicology research .
At Magic Psychedelics, we are committed to providing accurate, evidence-based educational resources for researchers exploring novel psychoactive substances. Understanding compounds like dechloroetizolam is essential for advancing analytical methods, harm reduction strategies, and regulatory science.
Related Research Topics
- Etizolam vs. Dechloroetizolam comparison
- Designer benzodiazepine metabolism
- Thienodiazepine pharmacology and GABA-A receptors
- Analytical methods for novel benzodiazepines
- Legal status of research chemicals by country
References
- Probes & Drugs Portal – Deschloroetizolam compound profile
- Benchchem – Deschloroetizolam product data
- The J Healthcare Initiative – Deschloroetizolam harm reduction profile
- SpringerLink – Forensic Toxicology: Characterization of designer benzodiazepines
- Wikipedia (German) – Deschloretizolam
- PubMed – Novel Designer Benzodiazepines review
- DrogArt – Deskloroetizolam warning and harm reduction
- The JHI – Deschloroetizolam dosage and effects
- PeptideDB – Deschloroetizolam product database
Disclaimer: This content is for educational and scientific research purposes only. Magic Psychedelics does not condone human consumption of research chemicals. All information is provided as a reference for laboratory and forensic applications. Always comply with local laws and regulations.
Internal Linking Suggestions (for SEO)
- Link to
/research-chemicals– “research chemicals” - Link to
/benzodiazepine-analogs– “designer benzodiazepines” - Link to
/analytical-standards– “reference standards”
External Authority Links
Let me know if you would like a product specification table, FAQ schema markup, or analytical data sheet to accompany this post for magic-psychedelics.com.